Literature DB >> 29356992

Identification and production of mouse scFv to specific epitope of enterovirus-71 virion protein-2 (VP2).

Jeeraphong Thanongsaksrikul1, Potjanee Srimanote2, Pongsri Tongtawe2, Kittirat Glab-Ampai3, Aijaz Ahmad Malik4, Oratai Supasorn2, Phatcharaporn Chiawwit2, Yong Poovorawan5, Wanpen Chaicumpa3.   

Abstract

Enterovirus-71 (EV71) and coxsackievirus-A16 (CA16) frequently cause hand-foot-mouth disease (HFMD) epidemics among infants and young children. CA16 infections are usually mild, while EV71 disease may be fatal due to neurologic complications. As such, the ability to rapidly and specifically recognize EV71 is needed to facilitate proper case management and epidemic control. Accordingly, the aim of this study was to generate antibodies to EV71-virion protein-2 (VP2) by phage display technology for further use in specific detection of EV71. A recombinant peptide sequence of EV71-VP2, carrying a predicted conserved B cell epitope fused to glutathione-S-transferase (GST) (designated GST-EV71-VP2/131-160), was produced. The fusion protein was used as bait in in-solution biopanning to separate protein-bound phages from a murine scFv (MuscFv) phage display library constructed from an immunoglobulin gene repertoire from naïve ICR mice. Three phage-transformed E. coli clones (clones 63, 82, and 83) produced MuscFvs that bound to the GST-EV71-VP2/131-160 peptide. The MuscFv of clone 83 (MuscFv83), which produced the highest ELISA signal to the target antigen, was further tested. MuscFv83 also bound to full-length EV71-VP2 and EV71 particles, but did not bind to GST, full-length EV71-VP1, or the antigenically related CA16. MuscFv83 could be a suitable reagent for rapid antigen-based immunoassay, such as immunochromatography (ICT), for the specific detection and/or diagnosis of EV71 infection as well as epidemic surveillance.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29356992     DOI: 10.1007/s00705-018-3731-z

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  4 in total

1.  Monoclonal antibody specific to the Dia blood group antigen generated by phage display technology.

Authors:  Phatchira Thattanon; Jeeraphong Thanongsaksrikul; Sawang Petvises; Oytip Nathalang
Journal:  Blood Transfus       Date:  2020-07-22       Impact factor: 3.443

Review 2.  Application of Phage-Displayed Peptides in Tumor Imaging Diagnosis and Targeting Therapy.

Authors:  Chunyan Li; Jia Li; Ying Xu; Ying Zhan; Yu Li; Tingting Song; Jiao Zheng; Hong Yang
Journal:  Int J Pept Res Ther       Date:  2020-09-03       Impact factor: 1.931

Review 3.  Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Authors:  Kristian Daniel Ralph Roth; Esther Veronika Wenzel; Maximilian Ruschig; Stephan Steinke; Nora Langreder; Philip Alexander Heine; Kai-Thomas Schneider; Rico Ballmann; Viola Fühner; Philipp Kuhn; Thomas Schirrmann; André Frenzel; Stefan Dübel; Maren Schubert; Gustavo Marçal Schmidt Garcia Moreira; Federico Bertoglio; Giulio Russo; Michael Hust
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

4.  Plant-Produced Anti-Enterovirus 71 (EV71) Monoclonal Antibody Efficiently Protects Mice Against EV71 Infection.

Authors:  Kaewta Rattanapisit; Zhang Chao; Konlavat Siriwattananon; Zhong Huang; Waranyoo Phoolcharoen
Journal:  Plants (Basel)       Date:  2019-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.